Working… Menu
Trial record 2 of 26 for:    rituximab radiotherapy | Lymphoma | Italy

High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement (SCNSL1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00801216
Recruitment Status : Unknown
Verified October 2008 by IRCCS San Raffaele.
Recruitment status was:  Recruiting
First Posted : December 3, 2008
Last Update Posted : December 3, 2008
Mundipharma K.K.
Information provided by:
IRCCS San Raffaele